Inspiring Sustainable API Solutions for Global Health

Innovating and manufacturing high-quality APIs for over two decades, Inke delivers expertise, safety, and excellence across Inhalation, CNS, and Ophthalmic therapies, supporting pharmaceutical companies globally.

Driving pharmaceutical innovation through advanced synthesis and cutting-edge micronization technologies, delivering high-quality APIs and ophthalmic solutions for a healthier future.

  • 2 Full cGMP Manufacturing Sites
  • Capabilities to find the right crystal shape and size
  • 25+ years experience in micronisation
  • OEB 4 SafeBridge® High-Containment Design for HPAPIs (<30 ng/m³), ensuring maximum operator safety
  • Critical in process controls and cleaning process validation in the whole process to assure the highest quality standards
  • Routine microbiological testing and strict quality control of levels of impurities, amorphous content and residual solvents
  • Complex chemical reactions and handling of hazardous chemicals
  • Chromatographic purification capabilities: HPLC and SFC from mg to kilos scale
  • Last stages under ISO-7 environmental conditions
Contact Us

Next Event

DCAT - The Premier Event for the Global Bio/Pharmaceutical Business Ecosystem

Join Inke at DCAT Week 2026

23 March – 26 March, 2026

New York City

Schedule a Meeting

Expertise that drives innovation across respiratory, CNS, and ophthalmic therapies

Inke stands out for its highly specialized respiratory portfolio of 12 APIs and 6 high-potency ophthalmic APIs. Combined with our CNS capabilities and a growing portfolio of 50+ products, our focus on innovation, containment safety, and regulatory excellence ensures high-quality solutions for complex therapies worldwide.

Our Global Presence

Inke’s Reach Across +40 International Markets

As a trusted partner to major generic and branded companies, Inke has solidified its position as a key supplier in the global pharmaceutical landscape. Headquartered in Barcelona, Spain, with 2 Full cGMP facilities, our reach extends far beyond borders, with a continuous international expansion spanning over two decades. Find your regional Business Development Manager below for tailored support and information.

 

Canada, USA & Mexico

For detailed information on this market, please reach out to Maite Pascual.

mtpascual@inke.es

Japan

For detailed information on this market, please reach out to Mónica Capón

mcapon@inke.es

Africa

Turkey, South Africa, MENA (Egypt, Algeria, Morocco & Tunisia)

For detailed information on this market, please reach out to Maite Pascual.

mtpascual@inke.es

India, Bangladesh & Pakistan

For detailed information on this market, please reach out to Maite Pascual.

mtpascual@inke.es

Inke Avinyonet Manufacturing Site - (Inke AV)

Main Offices:

Avinguda Diagonal, 605 6D,
08028 Barcelona, Spain

Inke Ophthalmics Manufacturing Site:

C/ Tramontana 3
08793 Avinyonet del Penedès, Barcelona, Spain

contact-inke@inke.es

Inke Castellbisbal Manufacturing Site - (Inke CB)

Main Offices:

Avinguda Diagonal, 605 6D,
08028 Barcelona, Spain

Manufacturing Site:

Area Industrial del Llobregat,
Argent 1, 08755 Castellbisbal
Barcelona, Spain

GPS address
contact-inke@inke.es

Inke US Office

53 State Street, Suite 500
Boston, MA, 02109.

GPS address

LATAM

Argentina & Brazil

For detailed information on this market, please reach out to Jorge Llorens.

jllorens@inke.es

Europe

For detailed information on this market, please reach out to Helena Kalaitzopoulos.

hkalaitzopoulos@inke.es

Spain

For detailed information on this market, please reach out to Maite Pascual.

mtpascual@inke.es

Asia & Oceania

China, Korea, Taiwan and Southest Asia (Vietnam, Philippines, Thailand & Malaysia), Australia & New Zealand

For detailed information on this market, please reach out to Harry Yuan.

hyuan@inke.es

Shaping the Future with Inke APIs

Explore Inke’s Complete API Portfolio

Discover our full range of high-quality active ingredients and innovative pipeline solutions, designed to support pharmaceutical excellence across multiple therapeutic areas.

View All Products

Inke’s milestones: driving innovation, quality, and regulatory excellence

25+

years of experience in micronisation

125+

granted patents

20+

years of succesful FDA Inspections

18250m2

Full cGMP facilities

111+

Registered DMFs and Granted CEPs

NewsRoom

Inke acquires Pharmanoid, a Highly Potent API manufacturing site specializing in ophthalmology

Why Micronization Matters in Respiratory Medicine

Inke in Numbers: When Scale Meets Precision

Inke participates in CPHI China 2025

Inke participates in the 10th Pulmonary Drug Delivery Conference

Inke in Numbers: Innovation that Drives Long-Term Value

Inke strengthens presence in China at the 92nd API China – Guangzhou

Inke participates in RDD Europe 2025

Formoterol Fumarate: Inke’s Flagship API for Respiratory Health

Key Takeaways from the 12th DPI China Technology Conference

Inke’s Near-Term Emissions Reduction Targets Approved by the SBTi

Reflecting on DCAT Week 2025: Key Insights and Industry Trends

Inke highlights the importance of European capital markets in EIB interview

Inke Confirms Its Presence at DCAT Week 2025

Inke Promotes Vanessa Martínez to HSE Director: Strengthening Our Commitment to Sustainability

Celebrating Inclusion on December 3rd – Inke & Eurofirms for Equal Opportunities

Inke Expands Its Reach in China with New DMF Approvals

Inke’s Key Insights from DDL 2024 – Shaping the Future of Inhalation APIs

Supporting Respiratory Health – Inke Joins La Marató 2024

Inke Achieves Aprepitant CEP and Salmeterol DMF – A Step Forward

Inke’s Leadership in Respiratory Health – An Interview with CEO Miquel Bachs

Read More

Unlocking Potential with Our CMO Services

Discover how Inke’s precision micronisation and expert CMO services can elevate your pharmaceutical products. Explore our capabilities and partner with us for exceptional quality and innovation.

Learn more